Figure 2From: Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials Risk Ratios for overall survival rates of all 10 randomized controlled trials. Back to article page